EUVIMEDEUVIMED entdecken
Crossref

Discovery of N ‐(phenylsulfonyl)thiazole‐2‐carboxamides as potent α ‐glucosidase inhibitors

Jun Liu iD, Jia-Hao Li, Si-Yu Zhao, Yi-Qun Chang, Qiu-Xian Chen, Wen-Fu Wu, Shu-Meng Jiao, Haichuan Xiao, Qiang Zhang, Jian-Fu Zhao, Jun Xu, Ping-Hua Sun

Drug Development Research · 2024

DOI: 10.1002/ddr.22128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Jun Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, PR China. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, Thiazoles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a search for novel nonsugar α ‐glucosidase inhibitors for diabetes treatment, a series of N ‐(phenylsulfonyl)thiazole‐2‐carboxamide derivatives were designed and synthesized, the α ‐glucosidase inhibitory activities were then evaluated. Several compounds with promising α ‐glucosidase inhibitory effects were identified. Among these, compound W24 which shows low cytotoxicity and good α ‐glucosidase inhibitory activity with an IC 50 value of 53.0 ± 7.7 μM, is more competitive compared with the commercially available drug acarbose (IC 50 = 228.3 ± 9.2 μM). W24 was identified as a promising candidate in the development of α ‐glucosidase inhibitors. Molecular docking studies and molecular dynamics simulation were also performed to reveal the binding pattern of the active compound to α ‐glucosidase, and the binding free energy of the best compound W24 was 36.3403 ± 3.91 kcal/mol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycoside Hydrolase InhibitorsThiazolesMolecular Docking SimulationStructure-Activity Relationshipalpha-GlucosidasesMolecular Structure

Stichwörter der Autor:innen

diabetesthiazoleα-glucosidase inhibitors

Substanzen

Glycoside Hydrolase InhibitorsThiazolesalpha-Glucosidases

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, PR China.
  • College of Pharmacy, Jinan University, Guangzhou, Guangdong, PR China.
  • Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Jun Liu

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Liu, J., Li, J. H., Zhao, S. Y., Chang, Y. Q., Chen, Q. X., Wu, W. F., Jiao, S. M., Xiao, H., Zhang, Q., Zhao, J. F., Xu, J., & Sun, P. H. (2024). Discovery of N ‐(phenylsulfonyl)thiazole‐2‐carboxamides as potent α ‐glucosidase inhibitors. Drug Development Research. https://doi.org/10.1002/ddr.22128

Vancouver

Liu J, Li JH, Zhao SY, Chang YQ, Chen QX, Wu WF, et al. Discovery of N ‐(phenylsulfonyl)thiazole‐2‐carboxamides as potent α ‐glucosidase inhibitors. Drug Development Research. 2024. doi:10.1002/ddr.22128

BibTeX
@article{Liu2024,
  author = {Liu, Jun and Li, Jia-Hao and Zhao, Si-Yu and Chang, Yi-Qun and Chen, Qiu-Xian and Wu, Wen-Fu and Jiao, Shu-Meng and Xiao, Haichuan and Zhang, Qiang and Zhao, Jian-Fu and Xu, Jun and Sun, Ping-Hua},
  title = {Discovery of N ‐(phenylsulfonyl)thiazole‐2‐carboxamides as potent α ‐glucosidase inhibitors},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22128}
}
Kostenlos starten →